{"id":"https://openalex.org/W19985279","doi":"https://doi.org/10.1177/135965350501000503","title":"A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Trial of Merimepodib (VX-497) and Interferon-\u03b1 in Previously Untreated Patients with Chronic Hepatitis C","display_name":"A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Trial of Merimepodib (VX-497) and Interferon-\u03b1 in Previously Untreated Patients with Chronic Hepatitis C","publication_year":2005,"publication_date":"2005-07-01","ids":{"openalex":"https://openalex.org/W19985279","doi":"https://doi.org/10.1177/135965350501000503","mag":"19985279","pmid":"https://pubmed.ncbi.nlm.nih.gov/16152757"},"language":"en","primary_location":{"id":"doi:10.1177/135965350501000503","doi":"https://doi.org/10.1177/135965350501000503","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350501000503","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350501000503","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350501000503","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064179616","display_name":"John G. McHutchison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4210146328","display_name":"Scripps Clinic","ror":"https://ror.org/05kwjwj05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210146328"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John G McHutchison","raw_affiliation_strings":["Division of Gastroenterology, Scripps Clinic, La Jolla, CA, USA","Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, Scripps Clinic, La Jolla, CA, USA","institution_ids":["https://openalex.org/I4210146328"]},{"raw_affiliation_string":"Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010968373","display_name":"Mitchell L. Shiffman","orcid":"https://orcid.org/0000-0002-3575-6516","observed_orcids":["https://orcid.org/0000-0002-3575-6516"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I72019824","display_name":"Virginia Commonwealth University Medical Center","ror":"https://ror.org/057xmsr27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I72019824"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mitchell L Shiffman","raw_affiliation_strings":["Hepatology Section, Virginia Commonwealth University Health System, Richmond, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hepatology Section, Virginia Commonwealth University Health System, Richmond, VA, USA","institution_ids":["https://openalex.org/I184840846","https://openalex.org/I72019824"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024464961","display_name":"Ramsey C Cheung","orcid":"https://orcid.org/0000-0002-0211-7013","observed_orcids":["https://orcid.org/0000-0002-0211-7013"]},"institutions":[{"id":"https://openalex.org/I204866599","display_name":"VA Palo Alto Health Care System","ror":"https://ror.org/00nr17z89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I204866599","https://openalex.org/I2799886695","https://openalex.org/I4210125474"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramsey C Cheung","raw_affiliation_strings":["VAPAHCS, Palo Alto, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VAPAHCS, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I204866599"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046835105","display_name":"Stuart C. Gordon","orcid":"https://orcid.org/0000-0001-8666-3849","observed_orcids":["https://orcid.org/0000-0001-8666-3849"]},"institutions":[{"id":"https://openalex.org/I4210128757","display_name":"Corewell Health William Beaumont University Hospital","ror":"https://ror.org/03artm726","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128757","https://openalex.org/I4392738273"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart C Gordon","raw_affiliation_strings":["William Beaumont Hospital, Royal Oak, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Beaumont Hospital, Royal Oak, MI, USA","institution_ids":["https://openalex.org/I4210128757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009050197","display_name":"Teresa Lyn Wright","orcid":"https://orcid.org/0000-0002-9174-9409","observed_orcids":["https://orcid.org/0000-0002-9174-9409"]},"institutions":[{"id":"https://openalex.org/I1315708478","display_name":"San Francisco VA Medical Center","ror":"https://ror.org/049peqw80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315708478","https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210143381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teresa L Wright","raw_affiliation_strings":["VA Medical Center, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VA Medical Center, San Francisco, CA, USA","institution_ids":["https://openalex.org/I1315708478"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058275680","display_name":"John C. Pottage","orcid":"https://orcid.org/0000-0002-5273-1783","observed_orcids":["https://orcid.org/0000-0002-5273-1783"]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C Pottage","raw_affiliation_strings":["Vertex Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060899169","display_name":"Lindsay A. McNair","orcid":"https://orcid.org/0000-0003-2458-8550","observed_orcids":["https://orcid.org/0000-0003-2458-8550"]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsay McNair","raw_affiliation_strings":["Vertex Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003973073","display_name":"Ene Ette","orcid":"https://orcid.org/0000-0003-3227-0454","observed_orcids":["https://orcid.org/0000-0003-3227-0454"]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ene Ette","raw_affiliation_strings":["Vertex Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035870078","display_name":"Scott Moseley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Moseley","raw_affiliation_strings":["Vertex Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023056842","display_name":"John J. Alam","orcid":"https://orcid.org/0000-0002-1285-1115","observed_orcids":["https://orcid.org/0000-0002-1285-1115"]},"institutions":[{"id":"https://openalex.org/I1315708478","display_name":"San Francisco VA Medical Center","ror":"https://ror.org/049peqw80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315708478","https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210143381"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I204866599","display_name":"VA Palo Alto Health Care System","ror":"https://ror.org/00nr17z89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I204866599","https://openalex.org/I2799886695","https://openalex.org/I4210125474"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4210128757","display_name":"Corewell Health William Beaumont University Hospital","ror":"https://ror.org/03artm726","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128757","https://openalex.org/I4392738273"]},{"id":"https://openalex.org/I4210146328","display_name":"Scripps Clinic","ror":"https://ror.org/05kwjwj05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210146328"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]},{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]},{"id":"https://openalex.org/I72019824","display_name":"Virginia Commonwealth University Medical Center","ror":"https://ror.org/057xmsr27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I72019824"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Alam","raw_affiliation_strings":["Vertex Pharmaceuticals, Cambridge, MA, USA","Division of Gastroenterology, Scripps Clinic, La Jolla, CA, USA","Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA","Hepatology Section, Virginia Commonwealth University Health System, Richmond, VA, USA","VA Medical Center, San Francisco, CA, USA","VAPAHCS, Palo Alto, CA, USA","William Beaumont Hospital, Royal Oak, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I61970326"]},{"raw_affiliation_string":"Division of Gastroenterology, Scripps Clinic, La Jolla, CA, USA","institution_ids":["https://openalex.org/I4210146328"]},{"raw_affiliation_string":"Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4405286153"]},{"raw_affiliation_string":"Hepatology Section, Virginia Commonwealth University Health System, Richmond, VA, USA","institution_ids":["https://openalex.org/I184840846","https://openalex.org/I72019824"]},{"raw_affiliation_string":"VA Medical Center, San Francisco, CA, USA","institution_ids":["https://openalex.org/I1315708478"]},{"raw_affiliation_string":"VAPAHCS, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I204866599"]},{"raw_affiliation_string":"William Beaumont Hospital, Royal Oak, MI, USA","institution_ids":["https://openalex.org/I4210128757"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":2.5204,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.88659112,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"10","issue":"5","first_page":"635","last_page":"643"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/impdh-inhibitors","display_name":"IMPDH inhibitors","score":0.6700000166893005},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8600000143051147},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9940000176429749},{"id":"https://openalex.org/keywords/hcv-genotype-1","display_name":"HCV genotype 1","score":0.8500000238418579},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.949999988079071},{"id":"https://openalex.org/keywords/combination-antiviral-therapy","display_name":"combination antiviral therapy","score":0.828000009059906},{"id":"https://openalex.org/keywords/hcv-rna-reduction","display_name":"HCV RNA reduction","score":0.8479999899864197},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.8809999823570251},{"id":"https://openalex.org/keywords/pharmacokinetic-interactions","display_name":"pharmacokinetic interactions","score":0.8230000138282776},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6620000004768372}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7927279472351074},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7881262302398682},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.649226188659668},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.6380185484886169},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6114785075187683},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6077102422714233},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5948206186294556},{"id":"https://openalex.org/C38596361","wikidata":"https://www.wikidata.org/wiki/Q6036610","display_name":"IMP dehydrogenase","level":4,"score":0.5842679142951965},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.5629141330718994},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49067413806915283},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4726925194263458},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.45790740847587585},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.41949838399887085},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41000884771347046},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.3611105978488922},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.339575856924057},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32817190885543823},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.22926902770996094},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.07629641890525818},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0755692720413208},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2778033501","wikidata":"https://www.wikidata.org/wiki/Q420553","display_name":"Mycophenolic acid","level":3,"score":0.0},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007168","descriptor_name":"IMP Dehydrogenase","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007168","descriptor_name":"IMP Dehydrogenase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D007168","descriptor_name":"IMP Dehydrogenase","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/135965350501000503","doi":"https://doi.org/10.1177/135965350501000503","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350501000503","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350501000503","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},{"id":"pmid:16152757","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16152757","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral therapy","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1177/135965350501000503","doi":"https://doi.org/10.1177/135965350501000503","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350501000503","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350501000503","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1655645242","display_name":"GENERAL CLINICAL RESEARCH CENTER","funder_award_id":"M01RR000833","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"}],"funders":[{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W19985279.pdf","grobid_xml":"https://content.openalex.org/works/W19985279.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1580125578","https://openalex.org/W1599050129","https://openalex.org/W1979770064","https://openalex.org/W1991022617","https://openalex.org/W2027545702","https://openalex.org/W2033219217","https://openalex.org/W2038234230","https://openalex.org/W2038621697","https://openalex.org/W2039441730","https://openalex.org/W2039884199","https://openalex.org/W2058524504","https://openalex.org/W2061294380","https://openalex.org/W2064521548","https://openalex.org/W2087867836","https://openalex.org/W2107414185","https://openalex.org/W2127685726","https://openalex.org/W2143746544","https://openalex.org/W2144801406","https://openalex.org/W2150123371","https://openalex.org/W2165715544","https://openalex.org/W2166633925","https://openalex.org/W2317554121","https://openalex.org/W2318431194","https://openalex.org/W2329851510","https://openalex.org/W4299960933"],"related_works":["https://openalex.org/W2065983650","https://openalex.org/W2038621697","https://openalex.org/W1991025183","https://openalex.org/W2411702670","https://openalex.org/W7099794021","https://openalex.org/W2444518024","https://openalex.org/W7100550604","https://openalex.org/W2003323067","https://openalex.org/W2150123371","https://openalex.org/W278629488"],"abstract_inverted_index":{"Inhibition":[0],"of":[1,8,12,20,37,46,89,97,106,112,120,157,172,225,245,261,273],"inosine":[2],"monophosphate":[3],"dehydrogenase":[4],"(IMPDH)":[5],"is":[6],"one":[7,149],"several":[9],"proposed":[10],"mechanisms":[11],"action":[13],"for":[14,24,91,176],"ribavirin":[15],"(RBV),":[16],"a":[17,32,38,74,177,216,246,256],"critical":[18],"component":[19],"the":[21,95,113,118,121,152,168,183,193,206,223,243,259,265,270],"current":[22],"treatment":[23,107,194],"chronic":[25],"hepatitis":[26],"C":[27],"(CHC).":[28],"This":[29],"study":[30,36,114],"was":[31,145,252],"double-blind,":[33],"placebo-controlled":[34],"dose-escalation":[35],"novel,":[39],"selective,":[40],"orally":[41],"active":[42],"small":[43],"molecule":[44],"inhibitor":[45,249],"IMPDH,":[47],"merimepodib":[48],"(VX-497":[49],"or":[50,77,83,196,291,298],"MMPD)":[51],"in":[52,78,180,182,219,222],"combination":[53,79,123,144,224],"with":[54,61,80,108,202,232,292],"standard":[55],"interferon-alpha":[56],"(IFN-alpha).":[57],"Fifty-four":[58],"treatment-naive":[59],"patients":[60,101,214],"genotype-1":[62],"CHC":[63],"were":[64,102,115,165],"randomized":[65],"to":[66,116,125,136,140,250,267,269,285],"receive":[67],"IFN-alpha":[68,200,203,230,233,251],"3":[69],"MIU":[70],"subcutaneously":[71],"three":[72],"times":[73],"week,":[75],"alone":[76,234,290],"100":[81,226],"mg":[82,85,227],"300":[84],"(every":[86],"8":[87],"h)":[88],"MMPD":[90,128,198,228,262],"4":[92,98],"weeks.":[93],"At":[94],"end":[96],"weeks,":[99],"all":[100],"offered":[103],"48":[104],"weeks":[105],"IFN-alpha/RBV.":[109],"The":[110,142],"objectives":[111],"evaluate":[117,126],"tolerability":[119],"IFN-alpha/MMPD":[122],"and":[124],"whether":[127,287],"had":[129],"an":[130],"on-treatment":[131],"effect":[132],"on":[133,212],"HCV-RNA,":[134],"similar":[135],"RBV":[137],"when":[138],"added":[139],"IFN-alpha.":[141,274],"drug":[143],"generally":[146],"well":[147,253],"tolerated;":[148],"patient":[150],"at":[151],"higher":[153],"dose":[154],"discontinued":[155],"because":[156],"elevated":[158],"alanine":[159],"aminotransferase":[160],"levels.":[161],"No":[162],"pharmacokinetic":[163],"interactions":[164],"evident":[166],"between":[167,192,197],"two":[169],"drugs.":[170],"Analysis":[171],"covariance":[173],"that":[174],"adjusted":[175],"baseline":[178],"imbalance":[179],"HCV-RNA":[181,221],"intent-to-treat":[184],"population":[185],"did":[186],"not":[187],"show":[188],"any":[189],"significant":[190],"differences":[191],"groups,":[195],"plus":[199,229],"compared":[201,231],"alone.":[204],"However,":[205],"per-protocol":[207],"primary":[208],"efficacy":[209,272],"analysis":[210],"based":[211],"treatment-compliant":[213],"demonstrated":[215],"greater":[217],"reduction":[218],"mean":[220],"(-1.78":[235],"log":[236],"vs":[237],"-0.86":[238],"log,":[239],"P=0.037).":[240],"In":[241,255],"conclusion,":[242],"addition":[244,260],"selective":[247],"IMPDH":[248],"tolerated.":[254],"low-dose":[257],"range,":[258],"may":[263],"have":[264],"potential":[266],"add":[268],"antiviral":[271],"Larger,":[275],"longer":[276],"duration":[277],"trials":[278],"incorporating":[279],"pegylated":[280],"IFN":[281],"would":[282,294],"be":[283],"required":[284],"determine":[286],"this":[288],"combination,":[289],"RBV,":[293],"increase":[295],"either":[296],"early":[297],"sustained":[299],"virological":[300],"response":[301],"rates.":[302]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}